Congratulations to PulseAI an Ulster University startup that has recently been announced as part of the Mayo Clinic Platform Accelerate Programme.
This programme will allow them to refine their AI-driven solutions.
PulseAI are a medical technology company that build AI-enabled software products designed to improve the accuracy, efficiency and scalability of Cardiac Diagnostics.
The Mayo Clinic Platform enables new knowledge, new solutions and new technologies through collaborations with health technology innovators to create a healthier world.
Mayo Clinic Platform Accelerate is excited to announce its fourth cohort consisting of nine innovative health tech startups from around the globe. The 20-week accelerator program offers the startups an opportunity to refine their AI-driven solutions, helping them move their business plans forward and providing them resources to improve patient care, faster.
“We are thrilled to welcome the new cohort of Mayo Clinic Platform_Accelerate,” says Jamie Sundsbak, partner relationship manager with Mayo Clinic Platform. “These companies are at the forefront of healthcare innovation, and we are excited to work with them to accelerate their groundbreaking solutions. Together, we can make a real difference in the lives of patients around the world.”
Using its powerful data network, Mayo Clinic Platform_Accelerate helps startups focus on validation and clinical readiness of their AI-driven solutions in line with healthcare industry standards. The program provides participants access to Mayo Clinic experts in regulatory, clinical, technology and business domains. As part of this in-kind investment, Mayo Clinic Platform has an equity position in the companies.
